Cost-effectiveness analysis of additional local prostate radio therapy in metastatic prostate cancer from a medicare ...
Metastatic prostate cancer remains a therapeutic challenge. Based on data of the STAMPEDE trial, patients with a low metastatic burden showed prolonged failure-free and overall survival when treated with prostate radio therapy (RT) in addition to standard …